Picture of Somalogic logo

SLGC — Somalogic News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Somalogic Inc reports results for the quarter ended in September - Earnings Summary

* Somalogic Inc  SLGC.OQ  reported a quarterly adjusted loss
of 18
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 20 cents per share.
    * Revenue was $41.71 million​; analysts expected $20.08
million. 
    * Somalogic Inc's reported EPS for the quarter was a loss
of 18
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Somalogic Inc shares had risen by 13.4% this quarter and
lost 71.7% so far this year.
    * The company reported a quarterly loss of $32.94 million.
    * Wall Street's median 12-month price target for Somalogic
Inc is
$8.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 04:40 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.20          -0.18          Beat
 Jun. 30 2022      -0.18          -0.13          Beat
 Mar. 31 2022      -0.16          -0.02          Beat
 Dec. 31 2021      -0.13          -0.13          Met

Recent news on Somalogic

See all news